NIH/National Institute of Allergy and Infectious Diseases

Diseases, Conditions, Syndromes

Remdesivir prevents MERS coronavirus disease in monkeys

The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), according to a new study from National Institutes of Health scientists. ...

Diseases, Conditions, Syndromes

Recent advances in addressing tuberculosis give hope for future

In September 2018, the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the ...

Diseases, Conditions, Syndromes

First human trial of monoclonal antibody to prevent malaria opens

A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. ...

page 11 from 40